×

Europe News London

  • LONDON, Oct 1- Peninsular Gold Ltd:. *Its unit, Raub Australian Gold Mining obtained an Islamic financing facility. for up to about $40 million.

  • *Weak economic data and Spain worries pressure euro. Investors also remain wary about the outlook for Spain, which is expected to need a full international bailout at it struggles to raise funds for deficit-laden regional governments while recapitalising its struggling banks.

  • LONDON-- The board of Anglo-Swiss mining company Xstrata PLC said Monday it is recommending shareholders accept merger terms with Swiss commodities trader Glencore PLC _ a deal that would create an industry behemoth with revenues of around $175 billion. Xstrata said in a statement it was supporting the offer of 3.05 Glencore shares for each Xstrata share.

  • *Arrium rejects bid, calling it undervalued and conditional. SYDNEY/ MELBOURNE, Oct 1- A consortium including Noble Group and POSCO urged Arrium.

  • By Kate Kelland LONDON, Oct 1- Extending treatment with Roche's. Analysts had said the Swiss firm, the world's biggest maker of cancer drugs, could lose up to $1.5 billion in revenue from the blockbuster medicine in the medium term if six months treatment had been shown to be just as effective.

  • LONDON, Oct 1- European shares edged higher on Monday, starting the new quarter with a bounce off three-week lows, as investors increased their exposure to cyclical sectors such as banks and miners.

  • LONDON, Oct 1- Britain's blue-chip index was fractionally higher early on Monday, led by miner Xstrata. after it gave its long-awaited blessing to trader Glencore's bid. Shares in Xstrata gained 1.6 percent as its board backed Glencore's bid after wrestling for three weeks to reconcile opposing demands from shareholders over the deal terms.

  • LONDON, Oct 1- Bwin.Party Digital Entertainment PLC:. *Sale of ongame to amaya gaming group inc. *sale of ongame, a leading b2b online poker network to amaya gaming for up to E25.0 million.

  • *HERA trial favours status quo, PHARE trial inconclusive* Experts say key message is one year of Herceptin is best* Results limit downside risk for Roche's Herceptin revenues By Kate Kelland LONDON, Oct 1- Extending treatment with Roche'S. Data from both trials were presented at the European Society of Medical Oncology conference in Vienna on Monday.

  • SYDNEY, Oct 1- Australian shares ended flat on Monday, giving up early gains after data showing China's manufacturing sector remained in contraction in September fuelled investor worries about weak global growth. Mining and steel maker Arrium.

  • LONDON, Oct 1- Extending treatment with Roche's. breast cancer drug Herceptin to two years from the one year current standard is not worth while, trial data showed on Monday, but shortening treatment to six months also looks unlikely to benefit patients.

  • Xstrata's non-executive directors have been considering the improved, final, offer from Glencore, the miner's largest shareholder, since Sept. 10- wrestling for three weeks to reconcile opposing demands from shareholders over the deal terms, the board and a more than 140 million pound retention package.

  • LONDON, Oct 1- Exillon Energy PLC:. *Well etp IV-2003 confirming 8.6 metres of effective net oil pay. *Well flowed water-free oil to the surface with a flow rate of 465 bbl/day.

  • LONDON, Oct 1- Sinclair IS Pharma PLC:. *Distribution agreement and placing to raise 9 mln stg. *Agreement with Valeant for Sculptra, and New-Fill in Western Europe, and an exclusive sub-distribution agreement for Succeev in Western Europe.

  • LONDON, Sept 28- Take on a little risk, maybe, but not too much.

  • *Bacit limited- intention to float.

  • SYDNEY, Oct 1- Australian shares finished flat on Monday, after data showing that while China's manufacturing sector had improved somewhat in September, it remained in contraction, heightening investors' worries about weak global economic growth.

  • LONDON, Oct 1- Hammerson PLC:. *Disposal of 10 gresham street, London ec2. *Sale of its office property at 10 gresham street, London ec2, for a total.

  • LONDON, Oct 1- British Land:.

  • LONDON, Oct 1- GW Pharmaceuticals PLC:.